We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.57 | 1.95% | 29.83 | 29.78 | 29.86 | 30.08 | 29.715 | 30.04 | 4,829,456 | 21:22:28 |
By Cecilia Butini
Roche Holding AG said Thursday that it has entered into a definitive share purchase agreement to acquire 100% of the outstanding shares in TIB Molbiol Group, a Germany-based biotechnology company focused on diagnostics and research.
The Swiss pharmaceutical major said the acquisition, which is expected to close in the fourth quarter of 2021, will enhance its molecular-diagnostics portfolio, including the identification of coronavirus variants.
"With this acquisition, we can expand our offering of tests of existing pathogens and our response to emerging pathogens and potential health threats," Thomas Schinecker, head of Roche Diagnostics, said.
No financial details of the acquisition were disclosed.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
September 09, 2021 01:39 ET (05:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions